A Dynamic Pulmonary-Systemic Framework for Understanding Progression from Pneumonia to ARDS

Category	Detail
Condition	Pneumonia, ARDS, and infection-associated organ dysfunction
Key Mechanisms	Pulmonary injury and systemic host-response dysfunction can interact; trajectories vary with pathogen characteristics, host response, timing, treatment, and clinical context.
Target Population	Patients with pneumonia or infection who may develop ARDS or infection-associated organ dysfunction
Care Setting	Clinical assessment and communication concerning pneumonia, ARDS, and infection-associated organ dysfunction

Pneumonia is the commonest direct pulmonary insult precipitating ARDS, but patients with comparable pathogens and lung involvement can have divergent trajectories.
Progression is not a fixed anatomical sequence: pneumonia may resolve, remain localized, enlarge, or evolve abruptly into diffuse injury.
Pneumonia, ARDS, and sepsis are overlapping but distinct diagnoses; none necessarily entails the others.
Radiological distribution and microbial burden alone do not establish biological stage, mechanism, or future trajectory.
Pneumonia and ARDS encompass varied tissue-level and biological patterns; neither corresponds to one immune phenotype.

The source proposes retaining separate definitions for pneumonia, ARDS, and sepsis for diagnosis and clinical communication.
The source defines sepsis as life-threatening organ dysfunction arising from a dysregulated host response to infection, not inflammation or bacteraemia alone.
Bilateral pneumonia does not equate to ARDS; radiology describes spatial distribution rather than biological stage.
Interpret microbial detection after treatment in context, as it may indicate colonization or non-viable material.

Assess pulmonary and systemic domains in relation to one another, including organ dysfunction and changes in lung injury.
Use serial imaging to describe abnormality distribution; imaging alone does not establish the mechanism or rate of progression.
Interpret clinical trajectory in light of pathogen characteristics, host-response state, timing, and previous treatment.

Pneumonia can progress abruptly to ARDS, shock, and early multiorgan involvement.
Pulmonary signals can contribute to systemic vascular leak, coagulopathy, circulatory dysfunction, and distant-organ injury.
Inflammatory signalling can coexist with impaired antigen presentation, lymphocyte dysfunction, and diminished pathogen clearance.
The Clinical Pulmonary Infection Score has limited accuracy in differentiating infection from colonization.

Patients with pneumonia or infection who may develop ARDS or infection-associated organ dysfunction.

The excerpt discusses the role of previous treatment in shaping trajectories but provides no drug dosing or prescribing regimen.

The source states that severe or bilateral pneumonia is not a required intermediate stage before ARDS.
Interpret diagnostic labels alongside pulmonary and systemic condition, host response, and clinical trajectory.
The source states that infection-related ARDS may fulfil Sepsis-3 criteria through acute respiratory organ dysfunction alone when criteria are met and dysfunction is attributable to infection.
Do not infer a single immune phenotype from a diagnosis of pneumonia or ARDS.